Charles L. Weaver, Ph.D.
Affiliations: | 2001 | Yeshiva University, New York, NY, United States |
Area:
Neuroscience BiologyGoogle:
"Charles Weaver"Mean distance: 17.39 (cluster 11)
Parents
Sign in to add mentor| Peter Davies | grad student | 2001 | Yeshiva University | |
| (Conformation-dependent tau antibodies, Alzheimer's disease, and related disorders.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ahn KC, Learman CR, Baker GB, et al. (2019) Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease? Journal of Korean Medical Science. 34: e297 |
| Maiti P, Plemmons A, Bowers Z, et al. (2019) Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin. Journal of Visualized Experiments : Jove |
| Underly R, Song MS, Dunbar GL, et al. (2015) Expression of Alzheimer-Type Neurofibrillary Epitopes in Primary Rat Cortical Neurons Following Infection with Enterococcus faecalis. Frontiers in Aging Neuroscience. 7: 259 |
| Weaver CL, Espinoza M, Kress Y, et al. (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiology of Aging. 21: 719-27 |
| Davies P, Andorfer C, Weaver CL, et al. (2000) APP and tau phosphorylation in early Alzheimer's disease Neurobiology of Aging. 21: 210-211 |
| Jicha GA, Weaver C, Lane E, et al. (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7486-94 |
| Anderton BH, Callahan L, Coleman P, et al. (1998) Dendritic changes in Alzheimer's disease and factors that may underlie these changes Progress in Neurobiology. 55: 595-609 |